Ghana: City Cancer Challenge | March 17 – March 18, 2022
Launched in 2017 by the Union for International Cancer Control (UICC), City Cancer Challenge (C/Can) is now a standalone foundation active in nine cities around the world.
In the coming years, C/Can will continue to grow as it pursues its mission of supporting cities around the world as they work to improve access to equitable, quality cancer care.
The inaugural Diagnostics Co-Creation Sprint: Kumasi brings together teams of diagnostic companies, start-ups, and local innovators with end users, governments, healthcare institutions and city stakeholders to conceptualise and design relevant solutions to address the access gap to cancer diagnostics.
You’ll work on one of three key diagnostic challenges – from implementing Quality Improvement, strengthening equitable access to imaging and nuclear medicine to ensuring the sustainability of diagnostic capabilities.
Define the next chapter in Quality Improvement for anatomic pathology in Kumasi – and help shape the vision for what good quality looks like. Together with solution providers and local end users, brainstorm, uncover, and ideate solutions to support the implementation of Quality Assurance more seamlessly, cost-effectively and rapidly across Kumasi’s network of laboratories. Then take your thinking beyond QA, and help to develop concrete, locally-adapted Quality Improvement initiatives, built around workflows, incentive systems, software, tools, equipment and technologies.
- Pathologists, Laboratory technicians and lab representatives
- Tech companies & companies in Laboratory Solutions
- IT infrastructure providers
- Regulatory body representatives
- International experts
The continuous progress in local cancer care systems is opening the door to the introduction of PET imaging in the region-where none currently exists anywhere in West Africa. Seize this early opportunity and turn a seed of an idea into an articulated vision and mission for a new local alliance for equitable diagnostic imaging in Ghana and the region of Ashanti. In collaboration with government leaders, private companies, development agencies and academic experts, assess and examine the potential pitfalls and key success factors to building an efficient system-approach that champions and enables equitable access to medical imaging and nuclear medicine.
- Government representatives
- International and local imaging companies
- Development agencies
- Private imaging centre operators
Equipment failure, breakdown and its recurring maintenance are a source of high and unpredictable costs, as well as causing massive disruption and delay to the delivery of quality diagnostic services for cancer patients. Rethink how to proactively optimise equipment utilisation, prevent equipment breakdown, and reduce repair turnaround times with a more elegant, usable system built on capacity development, strengthened procedures, transparency between local stakeholders and equipment manufacturers, vendor-neutrality, and reduced dependency on long term external support.
- Leaders of major hospitals
- Local pathology and medical imaging providers
- Local technical equipment maintenance leaders
- International Imaging OEMs
- International Laboratory OEMs
- Government representatives